Titre:
  • Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
Auteur:Reardon, David D.A.; Dresemann, Gregor; Taillibert, Sophie; Campone, Mario; van den Bent, Martin M.J.; Clement, Paul M J P.; Blomquist, Erik; Gordower, Laurence; Schultz, Henrik; Raizer, Jeffrey; Hau, Peter; Easaw, Jacob; Gil, Miguel; Tonn, Jörg Christian J.; Gijtenbeek, Anja M M A.; Schlegel, Uwe; Bergstrom, Per; Green, Sylvan S.B.; Weir, Alva Bowen A.; Nikolova, Zariana
Informations sur la publication:British Journal of Cancer, 101, 12, page (1995-2004)
Statut de publication:Publié, 2009-12
Sujet CREF:Cancérologie
Mots-clés:C-KIT
Glioblastoma
Imatinib mesylate
Platelet-derived growth factor
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0007-0920
info:doi/10.1038/sj.bjc.6605411
info:pii/6605411
info:scp/71649102124
info:pmid/19904263